NCT01712763View on ClinicalTrials.gov

Degarelix in the Treatment of Endometriosis Recurrence

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Endometriosis
Interventions
DRUG

degarelix

180 women will be treated with degarlix 120 mg, in only one administration covering three months

DRUG

Leuprolide Acetate 11.25 MG/ML (Enantone 11,25)

180 women will be treated with leuprolide acetate11.25 only once covering three months

Trial Locations (3)

Unknown

Albania Spitali Amerikan, Tirana

Nadezda Women's Health Hospital, Sofia

00153

Cerm-Hungaria, Rome

All Listed Sponsors
lead

Centre for Endocrinology and Reproductive Medicine, Italy

NETWORK

NCT01712763 - Degarelix in the Treatment of Endometriosis Recurrence | Biotech Hunter | Biotech Hunter